2020
DOI: 10.1002/14651858.cd009422.pub4
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin E supplementation in people with cystic fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 43 publications
0
3
0
1
Order By: Relevance
“…An earlier study by Kalvaria et al 24 also found that prevalence of vitamin E was higher in a sample of patients with CP when vitamin E to lipid ratio was determined (75%) compared with serum vitamin E alone (55%). Even in the cystic fibrosis literature, where research on fat‐soluble vitamins is more vast, many studies have failed to account for blood lipid when evaluating vitamin E status 25 …”
Section: Discussionmentioning
confidence: 99%
“…An earlier study by Kalvaria et al 24 also found that prevalence of vitamin E was higher in a sample of patients with CP when vitamin E to lipid ratio was determined (75%) compared with serum vitamin E alone (55%). Even in the cystic fibrosis literature, where research on fat‐soluble vitamins is more vast, many studies have failed to account for blood lipid when evaluating vitamin E status 25 …”
Section: Discussionmentioning
confidence: 99%
“…The CF care community has long been aggressively focused on the needs for antioxidant micronutrient supplements [12][13][14]16,17,[57][58][59], and particularly for the needs for lipophilic antioxidants such as vitamin E [17,18,23,24,[60][61][62][63]. Under strong inputs from the CF Foundation scientific community [14,16], a revised version of a micronutrient antioxidant cocktail was designed and is now marketed with this increased need in mind [58].…”
Section: Nuances For the Cf Communitymentioning
confidence: 99%
“…Publicaciones recientes proponen como enfoque terapéutico prometedor el uso de los metabolitos de la vitamina E para el tratamiento de enfermedades inflamatorias como el hígado graso no alcohólico, por lo que explorar opciones como el compuesto activo de la vitamina E, conocido como metabolito de cadena larga, derivado del metabolismo hepático del α-tocoferol resulta prometedor (53,55).…”
Section: Inflamación Enfermedades Hepáticas Y Vitamina Eunclassified